FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引：0
|
作者：
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构：
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
376P
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [21] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
  • [22] Efficacy of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX as first line chemotherapy for metastatic pancreatic cancer (mPC): Real world experiences.
    Hwang, Inhwang
    Kang, Jihoon
    Yoo, Changhoon
    Kim, Kyu-Pyo
    Jeong, Jae Ho
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
    Cho, In Rae
    Kang, Huapyong
    Jo, Jung Hyun
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    An, Chansik
    Park, Mi-Suk
    Bang, Seungmin
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (02) : 182 - 194
  • [24] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
    In Rae Cho
    Huapyong Kang
    Jung Hyun Jo
    Hee Seung Lee
    Moon Jae Chung
    Jeong Youp Park
    Seung Woo Park
    Si Young Song
    Chansik An
    Mi-Suk Park
    Seungmin Bang
    World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 182 - 194
  • [25] Efficacy and safety of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX (FFX) as first line chemotherapy for metastatic pancreatic cancer (mPC): Retrospective analysis
    Lee, K.
    Hwang, I.
    Kang, J.
    Yoo, C.
    Kim, K-P.
    Jeong, J. H.
    Chang, H-M.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [27] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world
    Marschner, Norbert
    Hegewisch-Becker, Susanna
    Reiser, Marcel
    von der Heyde, Eyck
    Bertram, Mathias
    Hollerbach, Stephan H.
    Kreher, Stephan
    Wolf, Thomas
    Binninger, Adrian
    Chiabudini, Marco
    Kaiser-Osterhues, Anja
    Jaenicke, Martina
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (03) : 458 - 469
  • [29] Upadacitinib real-world efficacy and safety in treatment of inflammatory bowel disease: an Australian single-centre experience
    Chen, Gordon
    Rao, Vikram
    Lo, Sheng Wei
    Koh, Elaine
    Kaul, Abha
    La Nauze, Richard
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 278 - 279
  • [30] FOLFIRINOX and gemcitabine/nab-paclitaxel efficacy in the treatment of locally advanced unresectable pancreatic adenocarcinoma.
    Bednar, Filip
    Ocuin, Lee Mayer
    Steve, Jennifer
    Zenati, Mazen S.
    Winters, Sharon
    Hogg, Melissa Ellen
    Bahary, Nathan
    Zeh, Herbert J.
    Zureikat, Amer H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345